Clinical Outcome of Atypical Endometrial Hyperplasia Diagnosed on an Endometrial Biopsy
Authors:
- Emad RakhaEmad Rakha
- Siew Chee WongSWSiew Chee Wong
- Irshad SoomroISIrshad Soomro
- Zia ChaudryZCZia Chaudry
- Aarti SharmaASAarti Sharma
- Suha DeenSDSuha Deen
- Stephen ChanSCStephen Chan
- Jafaru AbuJAJafaru Abu
- David NunnsDNDavid Nunns
- Karin WilliamsonKWKarin Williamson
- Angus McGregorAMAngus McGregor
- Robert HammondRHRobert Hammond
- 1 November 2012
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 36 (11) , 1683-1690
Abstract
The aims of this study were: (1) to review the rate of concurrent endometrial cancer in patients with a preoperative diagnosis of atypical endometrial hyperplasia (AEH); and (2) to determine the features of concurrent endometrial carcinoma and their impact on the subsequent management of AEH. We reviewed a retrospective series of 219 AEHs diagnosed locally in routine practice, over 24 years, and followed by a repeat biopsy or hysterectomy. Another series of 65 cases with a malignant diagnosis on preoperative sampling was included as a control group. Clinicopathologic parameters were obtained. In addition, published data on the risk of malignancy and features of malignant tumors after a diagnosis of AEH were collected and analyzed. This study reported on 2571 patients diagnosed in 31 published studies in addition to the current one. This showed a wide variation in the positive predictive value (PPV) of AEH in detecting endometrial cancer (6% to 63%) with an overall PPV of 37%. This variation is not only based on the differences among studies but also on the degree of atypia [mild/moderate (PPV 13%) or severe (PPV 50%)], the type of subsequent intervention (biopsy vs. hysterectomy), and more importantly the time period of diagnosis (around 20% in studies published before 1990s and up to 40% to 48% in recently published cases). Of the benign outcome cases, nearly 40% to 50% showed AEH with a potential risk of progressing to invasive carcinoma in 25% of cases. Malignant tumors after AEH diagnosis are associated with features of good prognosis with endometrioid morphology, lower grade, and early stage. Although the overall PPV of AEH is 37%, a figure of 40% to 48% is expected in the cases currently diagnosed in routine practice. Providing qualifying criteria for AEH will help identify its different associated risks and therefore should be included in routine pathology reports whenever possible. Unless there is a clinical contraindication, hysterectomy should be performed to treat concurrent carcinoma and to reduce the risk of subsequent carcinoma in nonmalignant cases with residual AEH.Keywords
This publication has 44 references indexed in Scilit:
- Complex Hyperplasia With and Without AtypiaObstetrics & Gynecology, 2010
- Presence of endometrial adenocarcinoma in situ in complex atypical endometrial hyperplasia is associated with increased incidence of endometrial carcinoma in subsequent hysterectomyLaboratory Investigation, 2009
- Biopsy histomorphometry predicts uterine myoinvasion by endometrial carcinoma: a Gynecologic Oncology Group studyHuman Pathology, 2008
- Endometrial Hyperplasia and Carcinoma in Endometrial PolypsInternational Journal of Gynecological Pathology, 2008
- Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health planBritish Journal of Cancer, 2007
- Preoperative and postoperative histopathological findings in patients with endometrial hyperplasiaMedicinski Pregled, 2007
- Hysteroscopic view in atypical endometrial hyperplasias: A correlation with pathologic findings on hysterectomy specimensJournal of Minimally Invasive Gynecology, 2006
- Coexisting endometrial cancer in patients with a preoperative diagnosis of atypical endometrial hyperplasiaJournal of Obstetrics and Gynaecology Research, 2004
- Endometrial hyperplasia and the risk of carcinomaInternational Journal of Gynecological Cancer, 1995
- Assessment of the Risk on Endometrial Cancer in Hyperplasia, by Means of Morphological and Morphometrical FeaturesPathology - Research and Practice, 1992